Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

被引:0
|
作者
Simke W. Waijer
Priya Vart
David Z. I. Cherney
Glenn M. Chertow
Niels Jongs
Anna Maria Langkilde
Johannes F. E. Mann
Ofri Mosenzon
John J. V. McMurray
Peter Rossing
Ricardo Correa-Rotter
Bergur V. Stefansson
Robert D. Toto
David C. Wheeler
Hiddo J. L. Heerspink
机构
[1] University of Groningen,Department of Clinical Pharmacy and Pharmacology
[2] University Medical Center Groningen,Department of Medicine, Division of Nephrology
[3] University Health Network and University of Toronto,Departments of Medicine and Epidemiology and Population Health
[4] Stanford University School of Medicine,Late
[5] AstraZeneca,Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D
[6] University of Erlangen-Nürnberg,KfH Kidney Center Munich, Germany, and Department of Medicine 4
[7] Hadassah Hebrew University Hospital,Diabetes Unit, Department of Internal Medicine
[8] University of Glasgow,Institute of Cardiovascular and Medical Sciences
[9] Steno Diabetes Center Copenhagen,Department of Clinical Medicine
[10] University of Copenhagen,Department of Internal Medicine
[11] The National Medical Science and Nutrition Institute Salvador Zubiran,Department of Renal Medicine
[12] UT Southwestern Medical Center,undefined
[13] University College London,undefined
[14] The George Institute for Global Health,undefined
来源
Diabetologia | 2022年 / 65卷
关键词
Albuminuria; Dapagliflozin; eGFR; KDIGO risk categories; Kidney outcome; SGLT2 inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1085 / 1097
页数:12
相关论文
共 50 条
  • [1] Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
    Waijer, Simke W.
    Vart, Priya
    Cherney, David Z., I
    Chertow, Glenn M.
    Jongs, Niels
    Langkilde, Anna Maria
    Mann, Johannes F. E.
    Mosenzon, Ofri
    McMurray, John J., V
    Rossing, Peter
    Correa-Rotter, Ricardo
    Stefansson, Bergur, V
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. DIABETOLOGIA, 2022, 65 (07) : 1085 - 1097
  • [2] Efficacy and safety of dapagliflozin on kidney and cardiovascular outcomes by baseline albuminuria: a secondary analysis of the DAPA-CKD trial
    Heerspink, H. J. Lambers
    Waijer, S. W.
    Vart, P.
    Cherney, D. Z. I.
    Chertow, G.
    Langkilde, A. M.
    McMurray, J. J. V.
    Rossing, P.
    Correa-Rotter, R.
    Stefansson, B. V.
    Toto, R.
    Wheeler, D.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 30 - 30
  • [3] Dapagliflozin Effect on Hospital Admissions in Patients With CKD: A Post Hoc Analysis of the DAPA-CKD Trial
    Schechter, Meir
    Jongs, Niels
    Chertow, Glenn
    Mosenzon, Ofri
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Langkilde, Anna Maria
    Sjostrom, David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 25 - 25
  • [4] The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
    Wheeler, David C.
    Stefansson, Bergur, V
    Batiushin, Mikhail
    Bilchenko, Oleksandr
    Cherney, David Z., I
    Chertow, Glenn M.
    Douthat, Walter
    Dwyer, Jamie P.
    Escudero, Elizabeth
    Pecoits-Filho, Roberto
    Furuland, Hans
    Gorriz, Jose Luis
    Greene, Tom
    Haller, Hermann
    Hou, Fan Fan
    Kang, Shin-Wook
    Isidto, Rey
    Khullar, Dinesh
    Mark, Patrick B.
    McMurray, John J., V
    Kashihara, Naoki
    Nowicki, Michal
    Persson, Frederik
    Correa-Rotter, Ricardo
    Rossing, Peter
    Toto, Robert D.
    Umanath, Kausik
    Van Bui, Pham
    Wittmann, Istvan
    Lindberg, Magnus
    Sjostrom, C. David
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (10) : 1700 - 1711
  • [5] DAPA-CKD: A Regional Analysis of Kidney and Cardiovascular Outcomes
    Correa-Rotter, Ricardo
    Vart, Priya
    Jongs, Niels
    Hou, Fan Fan
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Douthat, Walter
    Escudero, Elizabeth T.
    Isidto, Rey A.
    Khullar, Dinesh
    Bajaj, Harpreet S.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 724 - 724
  • [6] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD
    Schechter, Meir
    Jongs, Niels
    Chertow, Glenn M.
    Mosenzon, Ofri
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Rossing, Peter
    Langkilde, Anna Maria
    Sjostrom, C. David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : 59 - +
  • [7] The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial
    Heerspink, Hiddo J. L.
    Jongs, Niels
    Chertow, Glenn M.
    Langkilde, Anna Maria
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur V.
    Toto, Robert D.
    Wheeler, David C.
    Greene, Tom
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 35 - 36
  • [8] Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD)
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan Fan
    Lindberg, Magnus B.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Robert D.
    Langkilde, Ann Maria
    Heerspink, Hiddo J. L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (12) : 1111 - 1111
  • [9] Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)
    McMurray, John J.
    Wheeler, David C.
    Stefansson, Bergur V.
    Rotter, Ricardo Correa
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan Fan
    Lindberg, Magnus B.
    Rossing, Peter
    Sjostrom, David
    Toto, Robert D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. Lambers
    [J]. CIRCULATION, 2020, 142 (24) : E482 - E483
  • [10] Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial
    Persson, Frederik
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    Jongs, Niels
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Bajaj, Harpreet S.
    Stefansson, Bergur, V
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. DIABETES CARE, 2021, 44 (08) : 1894 - 1897